SanaCurrents on Syndax’s (SNDX) rising drug to treat rare, acute leukemias

By |2023-01-17T08:26:57-05:00January 15th, 2023|Tags: |

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Probability Sentiment SUMMARY Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is advancing the small [...]